• This analysis used self-reported survey data from Kantar Health's PaCeR (Patient-Centered Research) platform.
• A stratified random sampling approach was used, based on gender and age, to ensure weighted representativeness to the adult populations in each country (urban population for China).
Weighted estimates were from the US Census Bureau's International Data Base and the National Bureau of Statistics of China.
• The total number of T2D patients was n=1,273 in Japan and n=384 in urban China.
mEThOds

Japan
• Bivariate results of Japanese adults by PAM level (1-4) showed that higher activation levels were associated with:
Higher: mean age, % married, % retired, % college educated, household income, mean exercise days, and currently taking steps to lose weight. Lower: obesity and smoking rate
• In terms of outcomes, higher PAM scores were associated with:
Higher MCS scores. Lower activity impairment
• Level 1 adults were least likely to visit a healthcare provider, and least likely to get an annual check-up.
• Higher activated T2D patients had:
Higher Rx satisfaction (results not graphed). Lower HbA1c levels (results not graphed)
China
• Bivariate results of Chinese (urban) adults by PAM level (1-4) showed that higher activation levels were associated with:
Higher: mean age, % married, household income, and mean exercise days.
Higher MCS and PCS scores. Lower work productivity impairment
Higher MCS and PCS scores
• In China, the proportion of adults taking steps to lose weight did not differ by PAM levels (unlike the results in Japan, which show higher activated adults are more likely to take steps to lose weight than less activated adults).
• The multivariable analyses generally matched the bivariate results. That is, even after adjusting for covariates, the results remained consistent and higher PAM categories were associated with better outcomes. • All results were self-reported by PaCeR participants. No results were physician-verified (e.g., HbA1c level).
• Missing PAM values were possible, as outliers were removed.
lImITATIOns
• Higher patient activation is often associated with better health outcomes. Therefore, understanding where patients are on the activation continuum is important to tailor specific services and communications for patients to increase their level of activation and improve their outcomes.
• Understanding how patients with health conditions by differ activation level can inform stakeholders. Different messages and interventions may be required to progress patients from one activation level to the next.
• Further investigation of patients with certain health conditions by PAM level is needed to customize messaging to drive better activation and better outcomes. • Patient activation refers to an individual's knowledge, skill, and confidence in managing their health.
• Higher levels of patient activation are often associated with better clinical outcomes.
• As activation increases, patients better understand their treatment options, are more adherent, are more satisfied, and have more positive healthcare experiences.
• To date, there are few published studies that explore patient activation in Japan or China. • Health Habits Overweight/obese status, smoking status, drinking status, and mean days exercised in the past month.
BACKGrOund
• Resource utilization Respondents provided the following (related to their health condition(s), within the past six months): number of healthcare provider (HCP) visits, emergency room (ER) visits, and hospitalizations.
• Health-Related Quality of Life (HRQoL) HRQoL was assessed using Mental and Physical Component Summary scores (MCS and PCS) of the SF-12v2 3 .
• Work Productivity and Activity Impairment (WPAI) Impairment (in the past seven days) was assessed using the WPAI 4 scale. Overall work impairment (due to absenteeism and presenteeism, among those employed full-time) was expressed as a mean percentage (higher value means greater impairment). Activity impairment (among all respondents) was also expressed as a mean percentage.
• Diabetes Measures HbA1c level was assessed. Among T2D patients currently using a prescription medication (insulin or non-insulin), satisfaction with the prescription was rated on a seven-point Likert scale (1 = extremely dissatisfied to 7 = extremely satisfied).
Analyses
• Bivariate analyses were conducted to profile all adults and all patients with T2D by activation level by country T2D was chosen to illustrate disease-specific metrics by activation level.
Results were weighted, with unweighted sample sizes shown as a reference.
Subscript /superscript letters indicate statistically significance differences at a 95% confidence level between subgroups.
• Multivariable analyses were also conducted.
Generalized linear models (GLMs) predicted patient-reported outcomes, adjusting for patient characteristics.
Covariates included: age, Charlson Comorbidity Index (CCI), gender, exercise, alcohol use, smoking status, education level, employment status, and annual household income.
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